Brief: Aurobindo Pharma To Buy 100% Interest In Lannett Seller Holdco
30/07/2025 16:23
July 30 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA LTD - TO BUY 100% INTEREST IN LANNETT SELLER HOLDCO Source text: ID:nBSE8phxCw Further company coverage: ARBN.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11